This is of specific clinical interest, as therapeutic efficiency of postoperative ATIII substitution might not be limited to HCC patients as reported previously[16], but be presumably beneficial in all patients undergoing liver resection independent of underlying liver disease. This evidence concerns the gene SERPINC1 and liver disorder.